Associated Papers
The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.
Athanasiou D et al.
Progress in Retinal and Eye Research, 2018
Transcriptome profiling of NIH3T3 cell lines expressing opsin and the P23H opsin mutant identifies candidate drugs for the treatment of retinitis pigmentosa.
Chen Y et al.
Pharmacological Research, 2017
Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila.
Griciuc A et al.
Plos Genetics, 2010
Clearance of Rhodopsin(P23H) aggregates requires the ERAD effector VCP.
Griciuc A et al.
Biochimica Et Biophysica Acta, 2010
Select a paper to view details